Aether Industries Ltd - Globe Capital
Aether Industries Ltd
Closed
Price Band
Rs. 610-642
IPO Issue Period
May 24, 2022 to May 26, 2022
Issue Size
Rs.808.04 Cr.
Face value
Rs. 10 /-
Fresh issue
Rs. 627.00 Cr.
Offer for sale
Rs.181.04 Cr.
Minimum Shares for Retail
23shares
Listing on
NSE, BSE
Issue Type
Book Building
Registrar to the Issue
Link Intime India Private Ltd
Tentative Listing Date
June 3, 2022
QIB
Not More than 50% of the offer
NII
Not less than 15% of the offer
Retail
Not less than 35% of the offer

HDFC Bank Limited (Past IPO Performance)
Kotak Mahindra Capital Company Limited (Past IPO Performance)

Aether Industries Limited Incorporated in 2013, Aether Industries Limited is a manufacturer of speciality chemicals. The company is the sole manufacturer in India of chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone and Bifenthrin Alcohol.

The company has three business models: Large scale manufacturing of intermediates and speciality chemicals, CRAMS (contract research and manufacturing services) and Contract manufacturing.

Aether Industries has two manufacturing sites at Sachin in Surat, Gujarat. Manufacturing Facility 1 is a 3,500 square metre facility including R&D and Hydrogenation Facilities and Pilot Plant. Manufacturing Facility 2 encompasses roughly 10,500 square metres, with an installed capacity of 6,096 MT per year spread among three buildings and 16 production streams as of September 30, 2021.

As of March 31, 2022, Aether Industries Limited’s product portfolio comprised over 25 products which were sold to over 34 global companies in 18 countries and to over 154 domestic companies. The company is the largest manufacturer of 4MEP, T2E, NODG and HEEP products in the world by volume.

For year/ period ended ( in Cr.)

H1FY22 FY21 FY20
Total Revenue
Profit After Tax
EPS
OPM (%)
PATM (%)
  • Differentiated portfolio of market-leading products.
  • Focus on R&D to leverage the core competencies of chemistry and technology.
  • Long-standing relationships with a diversified customer base.
  • Synergistic Business Models focused on Large Scale Manufacturing, CRAMS and Contract Manufacturing.
  • Focus on Quality, Environment, Health and Safety (QEHS).
  • Strong and consistent financial performance.
  • Experienced Promoters and Senior Management with extensive domain knowledge.

1. Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the Company.

2. Funding capital expenditure requirements for the manufacturing facility  (Proposed Greenfield Project).

3. Funding working capital requirements of the Company.

4. General corporate purposes.

Open Account